RxNorm Semantic Concepts Index - 257
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "257".
| RxCUI | Name | Term Type | Term Type Description | Is Prescribable? |
|---|---|---|---|---|
| RxCUI: 25700 | Gentamicin acetyltransferase 1 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 25700 | Gentamicin acetyltransferase 1 | Designated preferred name (PT) | NO | |
| RxCUI: 25700 | Gentamicin acetyltransferase 1 | Full form of descriptor (FN) | NO | |
| RxCUI: 25700 | Gentamicin acetyltransferase 1 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2570160 | Mallotus japonicus bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2570280 | Dendrobium moniliforme whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2570281 | Prunus persica twig extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2570387 | samidorphan L-malate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2570388 | samidorphan 10 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2570389 | olanzapine / samidorphan Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2570389 | olanzapine / samidorphan Oral Product | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2570390 | olanzapine / samidorphan Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2570390 | olanzapine / samidorphan Pill | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2570391 | olanzapine / samidorphan Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2570391 | olanzapine / samidorphan Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2570392 | OLANZapine 5 MG / samidorphan 10 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2570392 | OLANZapine 5 MG / samidorphan 10 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2570392 | OLANZapine 5 MG / samidorphan 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2570392 | OLANZapine 5 MG / samidorphan 10 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2570392 | OLANZapine 5 MG / samidorphan 10 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2570393 | Lybalvi | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2570394 | olanzapine 5 MG / samidorphan 10 MG [Lybalvi] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2570394 | olanzapine 5 MG / samidorphan 10 MG [Lybalvi] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2570395 | Lybalvi Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2570396 | Lybalvi Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2570397 | olanzapine / samidorphan Oral Tablet [Lybalvi] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2570397 | olanzapine / samidorphan Oral Tablet [Lybalvi] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2570398 | LYBALVI 5 MG / 10 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2570398 | LYBALVI 5 MG / 10 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2570398 | LYBALVI 5 MG / 10 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2570398 | LYBALVI 5 MG / 10 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2570398 | LYBALVI 5 MG / 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2570398 | LYBALVI 5 MG / 10 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2570398 | LYBALVI 5 MG / 10 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2570399 | OLANZapine 10 MG / samidorphan 10 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2570399 | OLANZapine 10 MG / samidorphan 10 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2570399 | OLANZapine 10 MG / samidorphan 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2570399 | OLANZapine 10 MG / samidorphan 10 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2570399 | OLANZapine 10 MG / samidorphan 10 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2570400 | olanzapine 10 MG / samidorphan 10 MG [Lybalvi] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2570400 | olanzapine 10 MG / samidorphan 10 MG [Lybalvi] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2570401 | LYBALVI 10 MG / 10 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2570401 | LYBALVI 10 MG / 10 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2570401 | LYBALVI 10 MG / 10 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2570401 | LYBALVI 10 MG / 10 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2570401 | LYBALVI 10 MG / 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2570401 | LYBALVI 10 MG / 10 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2570401 | LYBALVI 10 MG / 10 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2570402 | OLANZapine 15 MG / samidorphan 10 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2570402 | OLANZapine 15 MG / samidorphan 10 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2570402 | OLANZapine 15 MG / samidorphan 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2570402 | OLANZapine 15 MG / samidorphan 10 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2570402 | OLANZapine 15 MG / samidorphan 10 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2570403 | olanzapine 15 MG / samidorphan 10 MG [Lybalvi] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2570403 | olanzapine 15 MG / samidorphan 10 MG [Lybalvi] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2570404 | LYBALVI 15 MG / 10 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2570404 | LYBALVI 15 MG / 10 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2570404 | LYBALVI 15 MG / 10 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2570404 | LYBALVI 15 MG / 10 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2570404 | LYBALVI 15 MG / 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2570404 | LYBALVI 15 MG / 10 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2570404 | LYBALVI 15 MG / 10 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2570405 | OLANZapine 20 MG / samidorphan 10 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2570405 | OLANZapine 20 MG / samidorphan 10 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2570405 | OLANZapine 20 MG / samidorphan 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2570405 | OLANZapine 20 MG / samidorphan 10 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2570405 | OLANZapine 20 MG / samidorphan 10 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2570406 | olanzapine 20 MG / samidorphan 10 MG [Lybalvi] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2570406 | olanzapine 20 MG / samidorphan 10 MG [Lybalvi] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2570407 | LYBALVI 20 MG / 10 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2570407 | LYBALVI 20 MG / 10 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2570407 | LYBALVI 20 MG / 10 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2570407 | LYBALVI 20 MG / 10 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2570407 | LYBALVI 20 MG / 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2570407 | LYBALVI 20 MG / 10 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2570407 | LYBALVI 20 MG / 10 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2570413 | Bacillus coagulans 2500000000 UNT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2570414 | Bacillus coagulans 2,500,000,000 UNT Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2570414 | Bacillus coagulans 2,500,000,000 UNT Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2570414 | Bacillus coagulans 2,500,000,000 UNT Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2570415 | methylsulfonylmethane 333.33 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2570416 | glucosamine sulfate 500 MG / methylsulfonylmethane 333.33 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2570416 | glucosamine sulfate 500 MG / methylsulfonylmethane 333.33 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2570416 | glucosamine sulfate 500 MG / methylsulfonylmethane 333.33 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2570417 | chondroitin sulfates 400 MG / glucosamine sulfate 500 MG / methylsulfonylmethane 333.33 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2570417 | chondroitin sulfates 400 MG / glucosamine sulfate 500 MG / methylsulfonylmethane 333.33 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2570417 | chondroitin sulfates 400 MG / glucosamine sulfate 500 MG / methylsulfonylmethane 333.33 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2570418 | paliperidone palmitate 1092 in 3.5 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2570418 | paliperidone palmitate 1092 in 3.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2570418 | paliperidone palmitate 1092 in 3.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2570419 | Invega Hayfera 1092 MG in 3.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2570419 | Invega Hayfera 1092 MG in 3.5 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2570419 | Invega Hayfera 1092 MG in 3.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2570419 | Invega Hayfera 1092 MG in 3.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2570420 | paliperidone palmitate 1560 MG in 5 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2570420 | paliperidone palmitate 1560 MG in 5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2570420 | paliperidone palmitate 1560 MG in 5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2570421 | Invega Hayfera 1560 MG in 5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2570421 | Invega Hayfera 1560 MG in 5 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2570421 | Invega Hayfera 1560 MG in 5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2570421 | Invega Hayfera 1560 MG in 5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2570477 | Curculigo orchioides whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2570479 | cholecalciferol / vitamin K2 Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2570480 | cholecalciferol 1250 MCG / vitamin K2 200 MCG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2570480 | cholecalciferol 1250 MCG / vitamin K2 200 MCG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2570480 | cholecalciferol 1250 MCG / vitamin K2 200 MCG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2570480 | cholecalciferol 1250 MCG / vitamin K2 200 MCG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2570493 | Capsicum | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2570493 | Capsicum | Designated preferred name (PT) | NO | |
| RxCUI: 2570493 | Capsicum | Full form of descriptor (FN) | NO | |
| RxCUI: 2570563 | 1-(2,3,8,8-tetramethyl-1,2,3,4,5,6,7,8-octahydronaphthalen-2-yl)ethanone, trans-(+/-)- | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2570564 | PEG-40 sorbitan peroleate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2570566 | camphor 3.2 % / menthol 7.4 % / methyl salicylate 12.5 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2570566 | camphor 3.2 % / menthol 7.4 % / methyl salicylate 12.5 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2570566 | camphor 3.2 % / menthol 7.4 % / methyl salicylate 12.5 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 25707 | Gentisate oxygenase | Designated preferred name (PT) | NO | |
| RxCUI: 25707 | Gentisate oxygenase | Full form of descriptor (FN) | NO | |
| RxCUI: 25707 | Gentisate oxygenase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2570729 | Cirsium japonicum extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2570730 | Crataegus pinnatifida whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2570731 | Artemisia capillaris whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2570732 | quaternium-90 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2570733 | Rubus coreanus whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2570734 | sodium ferrocyanide decahydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 2570735 | Ziziphus jujuba var. inermis whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2570736 | mobocertinib | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2570737 | mobocertinib succinate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 2570738 | mobocertinib 40 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2570739 | mobocertinib Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2570740 | mobocertinib Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2570741 | mobocertinib Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2570742 | mobocertinib 40 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2570742 | mobocertinib 40 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2570742 | mobocertinib 40 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2570743 | Exkivity | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2570744 | mobocertinib 40 MG [Exkivity] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2570745 | Exkivity Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2570746 | Exkivity Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2570747 | mobocertinib Oral Capsule [Exkivity] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2570748 | EXKIVITY 40 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2570748 | EXKIVITY 40 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2570748 | EXKIVITY 40 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2570748 | EXKIVITY 40 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2570749 | ruxolitinib 15 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2570750 | ruxolitinib Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2570751 | ruxolitinib Topical Cream | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2570752 | ruxolitinib 15 MG/ML Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2570752 | ruxolitinib 15 MG/ML Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2570752 | ruxolitinib 15 MG/ML Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2570752 | ruxolitinib 15 MG/ML Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2570753 | Opzelura | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2570754 | ruxolitinib 15 MG/ML [Opzelura] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2570755 | Opzelura Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2570756 | ruxolitinib Topical Cream [Opzelura] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2570757 | Opzelura 1.5 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2570757 | Opzelura 1.5 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2570757 | Opzelura 1.5 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2570757 | Opzelura 1.5 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2570757 | Opzelura 1.5 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2570860 | povidone 0.5 % Ophthalmic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2570860 | povidone 0.5 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2570860 | povidone 0.5 % Ophthalmic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2571 | Human leukocyte antigen (HLA) class I antigen | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| RxCUI: 2571 | Human leukocyte antigen (HLA) class I antigen | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2571 | Human leukocyte antigen (HLA) class I antigen | Designated preferred name (PT) | NO | |
| RxCUI: 2571 | Human leukocyte antigen (HLA) class I antigen | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| RxCUI: 2571 | Human leukocyte antigen (HLA) class I antigen | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| RxCUI: 2571 | Human leukocyte antigen (HLA) class I antigen | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2571 | Human leukocyte antigen (HLA) class I antigen | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2571 | Human leukocyte antigen (HLA) class I antigen | Full form of descriptor (FN) | NO | |
| RxCUI: 2571 | Human leukocyte antigen (HLA) class I antigen | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2571072 | Symphyotrichum oblongifolium whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2571073 | maralixibat chloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2571074 | maralixibat | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2571075 | maralixibat 9.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2571076 | maralixibat Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2571077 | maralixibat Oral Liquid Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2571078 | maralixibat Oral Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2571079 | maralixibat 9.5 MG/mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2571079 | maralixibat 9.5 MG/mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2571079 | maralixibat 9.5 MG/mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2571080 | Livmarli | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2571081 | maralixibat 9.5 MG/ML [Livmarli] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2571082 | Livmarli Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2571083 | Livmarli Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2571084 | maralixibat Oral Solution [Livmarli] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2571085 | Livmarli 9.5 MG/mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2571085 | Livmarli 9.5 MG/mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2571085 | Livmarli 9.5 MG/mL Oral Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2571086 | sodium bicarbonate 1976 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2571087 | citric acid 1000 MG / sodium bicarbonate 1976 MG Effervescent Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2571087 | citric acid 1000 MG / sodium bicarbonate 1976 MG Effervescent Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2571087 | citric acid 1000 MG / sodium bicarbonate 1976 MG Effervescent Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2571090 | Fraxinus latifolia whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2571093 | tisotumab vedotin-tftv | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2571094 | tisotumab vedotin | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2571095 | tisotumab | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2571096 | tisotumab vedotin-tftv 40 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2571097 | tisotumab Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2571098 | tisotumab Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2571099 | tisotumab vedotin-tftv 40 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2571099 | tisotumab vedotin-tftv 40 MG Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2571100 | Tivdak | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2571101 | tisotumab vedotin-tftv 40 MG [Tivdak] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2571102 | Tivdak Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2571103 | tisotumab Injection [Tivdak] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2571104 | tivdak 40 MG Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2571104 | tivdak 40 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2571104 | tivdak 40 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2571293 | Pneumococcal 15-valent conjugate vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2571293 | Pneumococcal 15-valent conjugate vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2571293 | Pneumococcal 15-valent conjugate vaccine | Designated preferred name (PT) | NO | |
| RxCUI: 2571293 | Pneumococcal 15-valent conjugate vaccine | Full form of descriptor (FN) | NO | |
| RxCUI: 2571350 | ethanol 71 % Medicated Pad | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2571350 | ethanol 71 % Medicated Pad | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2571350 | ethanol 71 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2571350 | ethanol 71 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 25714 | Geranoyl-CoA carboxylase | Designated preferred name (PT) | NO | |
| RxCUI: 25714 | Geranoyl-CoA carboxylase | Full form of descriptor (FN) | NO | |
| RxCUI: 25716 | Sabinene-hydrate synthase | Designated preferred name (PT) | NO | |
| RxCUI: 25716 | Sabinene-hydrate synthase | Full form of descriptor (FN) | NO | |
| RxCUI: 2571661 | menthyl ethylamido oxalate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2571664 | sulfacetamide sodium 9.8 % Medicated Shampoo | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2571664 | sulfacetamide sodium 9.8 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2571664 | sulfacetamide sodium 9.8 % Medicated Shampoo | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2571679 | atoltivimab-ebgn 33.3 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2571680 | maftivimab-ebgn 33.3 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2571681 | odesivimab-ebgn 33.3 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2571682 | atoltivimab-maftivimab-odesivimab-ebgn 483.3 MG / 483.3 MG / 483.3 MG in 14.5 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2571682 | atoltivimab-maftivimab-odesivimab-ebgn 483.3 MG / 483.3 MG / 483.3 MG in 14.5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2571682 | atoltivimab-maftivimab-odesivimab-ebgn 483.3 MG / 483.3 MG / 483.3 MG in 14.5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2571682 | atoltivimab-maftivimab-odesivimab-ebgn 483.3 MG / 483.3 MG / 483.3 MG in 14.5 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2571682 | atoltivimab-maftivimab-odesivimab-ebgn 483.3 MG / 483.3 MG / 483.3 MG in 14.5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2571683 | atoltivimab-ebgn 33.3 MG/ML / maftivimab-ebgn 33.3 MG/ML / odesivimab-ebgn 33.3 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2571684 | atoltivimab-ebgn 33.3 MG/ML / maftivimab-ebgn 33.3 MG/ML / odesivimab-ebgn 33.3 MG/ML [Inmazeb] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2571685 | Inmazeb 483.3 MG / 483.3 MG / 483.3 MG in 14.5 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2571685 | Inmazeb 483.3 MG / 483.3 MG / 483.3 MG in 14.5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2571685 | Inmazeb 483.3 MG / 483.3 MG / 483.3 MG in 14.5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2571685 | Inmazeb 483.3 MG / 483.3 MG / 483.3 MG in 14.5 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2571685 | Inmazeb 483.3 MG / 483.3 MG / 483.3 MG in 14.5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2571686 | atoltivimab-ebgn 33.3 MG/ML / maftivimab-ebgn 33.3 MG/ML / odesivimab-ebgn 33.3 MG/ML Injection [Inmazeb] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 25717 | Bornyl pyrophosphate synthase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 25717 | Bornyl pyrophosphate synthase | Designated preferred name (PT) | NO | |
| RxCUI: 25717 | Bornyl pyrophosphate synthase | Full form of descriptor (FN) | NO | |
| RxCUI: 2571801 | somapacitan-beco 3.3 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2571802 | somapacitan-beco 5 MG in 1.5 ML Pen Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2571802 | somapacitan-beco 5 MG in 1.5 ML Pen Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2571802 | somapacitan-beco 5 MG in 1.5 ML Pen Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2571802 | somapacitan-beco 5 MG in 1.5 ML Pen Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2571803 | somapacitan-beco 3.3 MG/ML Pen Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2571804 | somapacitan-beco 3.3 MG/ML [Sogroya] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2571805 | Sogroya 5 MG in 1.5 ML Pen Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2571805 | Sogroya 5 MG in 1.5 ML Pen Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2571805 | Sogroya 5 MG in 1.5 ML Pen Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2571805 | Sogroya 5 MG in 1.5 ML Pen Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2571806 | somapacitan-beco 3.3 MG/ML Pen Injector [Sogroya] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2571806 | somapacitan-beco 3.3 MG/ML Pen Injector [Sogroya] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2571811 | p-nitrobiphenyl | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2571812 | Prunus mume flower oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2571813 | atogepant | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2571832 | atogepant 10 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2571833 | atogepant Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2571834 | atogepant Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2571835 | atogepant Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2571836 | atogepant 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2571836 | atogepant 10 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2571837 | Qulipta | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2571838 | atogepant 10 MG [Qulipta] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2571839 | Qulipta Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2571840 | Qulipta Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2571841 | atogepant Oral Tablet [Qulipta] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2571842 | QULIPTA 10 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2571842 | QULIPTA 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2571842 | QULIPTA 10 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2571843 | atogepant 30 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2571844 | atogepant 30 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2571844 | atogepant 30 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2571845 | atogepant 30 MG [Qulipta] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2571846 | QULIPTA 30 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2571846 | QULIPTA 30 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2571846 | QULIPTA 30 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2571847 | atogepant 60 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2571848 | atogepant 60 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2571848 | atogepant 60 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2571849 | atogepant 60 MG [Qulipta] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2571850 | QULIPTA 60 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2571850 | QULIPTA 60 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2571850 | QULIPTA 60 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2571851 | casirivimab 300 MG in 2.5 ML Injection, 1 vial / imdevimab 300 MG in 2.5 ML Injection, 1 vial (EUA) | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 2571851 | casirivimab 300 MG in 2.5 ML Injection, 1 vial / imdevimab 300 MG in 2.5 ML Injection, 1 vial (EUA) | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2571852 | fluorodopa | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2571853 | Fluoro-L-dopa (18-F) | Designated preferred name (PT) | YES | |
| RxCUI: 2571853 | Fluoro-L-dopa (18-F) | Full form of descriptor (FN) | YES | |
| RxCUI: 2571853 | Fluoro-L-dopa (18-F) | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2571853 | Fluoro-L-dopa (18-F) | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2571854 | ioflupane | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2571855 | californium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2571856 | technetium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2571857 | florbetaben | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2571858 | flortaucipir | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2571859 | fluciclovine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2571860 | 2-phenyldodecane-p-sulfonate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2571989 | potassium lactate, DL- | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 2571991 | dihydroeugenol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2571992 | Capaction | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2571993 | nitenpyram 11.4 MG [Capaction] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2571994 | Capaction Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2571995 | Capaction Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2571996 | nitenpyram Oral Tablet [Capaction] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2571997 | Capaction 11.4 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2571997 | Capaction 11.4 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2571997 | Capaction 11.4 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2571998 | nitenpyram 57 MG [Capaction] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2571999 | Capaction 57 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2571999 | Capaction 57 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2571999 | Capaction 57 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2572001 | brexucabtagene autoleucel 1471000 CELLS/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2572002 | brexucabtagene autoleucel 100,000,000 CELLS per 68 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2572002 | brexucabtagene autoleucel 100,000,000 CELLS per 68 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2572002 | brexucabtagene autoleucel 100,000,000 CELLS per 68 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2572003 | brexucabtagene autoleucel 1471000 CELLS/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2572004 | brexucabtagene autoleucel 1471000 CELLS/ML [Tecartus] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2572005 | Tecartus 100,000,000 CELLS in 68 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2572005 | Tecartus 100,000,000 CELLS in 68 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2572005 | Tecartus 100,000,000 CELLS in 68 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2572005 | Tecartus 100,000,000 CELLS in 68 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2572006 | brexucabtagene autoleucel 1471000 CELLS/ML Injection [Tecartus] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2572006 | brexucabtagene autoleucel 1471000 CELLS/ML Injection [Tecartus] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2572014 | lidocaine HCl 4 % / menthol 4 % Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2572014 | lidocaine HCl 4 % / menthol 4 % Medicated Patch | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2572014 | lidocaine HCl 4 % / menthol 4 % Medicated Patch | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2572023 | dextromethorphan HBr 20 MG / guaiFENesin 200 MG / phenylephrine HCl 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2572023 | dextromethorphan HBr 20 MG / guaiFENesin 200 MG / phenylephrine HCl 10 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2572023 | dextromethorphan HBr 20 MG / guaiFENesin 200 MG / phenylephrine HCl 10 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2572100 | avacopan | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2572100 | avacopan | Designated preferred name (PT) | YES | |
| RxCUI: 2572100 | avacopan | Full form of descriptor (FN) | YES | |
| RxCUI: 2572100 | avacopan | Designated preferred name (PT) | YES | |
| RxCUI: 2572100 | avacopan | Full form of descriptor (FN) | YES | |
| RxCUI: 2572101 | avacopan 10 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2572102 | avacopan Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2572102 | avacopan Oral Product | Designated preferred name (PT) | YES | |
| RxCUI: 2572102 | avacopan Oral Product | Full form of descriptor (FN) | YES | |
| RxCUI: 2572103 | avacopan Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2572104 | avacopan Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2572105 | avacopan 10 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2572105 | avacopan 10 MG Oral Capsule | Designated preferred name (PT) | YES | |
| RxCUI: 2572105 | avacopan 10 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2572105 | avacopan 10 MG Oral Capsule | Full form of descriptor (FN) | YES | |
| RxCUI: 2572106 | Tavneos | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2572107 | avacopan 10 MG [Tavneos] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2572108 | Tavneos Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2572109 | Tavneos Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2572110 | avacopan Oral Capsule [Tavneos] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2572111 | TAVNEOS 10 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2572111 | TAVNEOS 10 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2572111 | TAVNEOS 10 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2572112 | .alpha.-ionene | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2572113 | octenylsuccinic anhydride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2572114 | benzalkonium chloride 0.13 % / benzocaine 5 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2572114 | benzalkonium chloride 0.13 % / benzocaine 5 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2572114 | benzalkonium chloride 0.13 % / benzocaine 5 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2572128 | thrombin, human 1200 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2572130 | thrombin, human 1200 UNT/ML [Evithrom] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2572132 | thrombin, bovine 2000 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2572134 | thrombin, bovine 2000 UNT/ML [Thrombin-JMI] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2572137 | thrombin, bovine 2000 UNT/ML [Thrombogen] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2572142 | fibrinogen, human 888 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2572143 | thrombin, human 3870 UNT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2572145 | fibrinogen, human 888 MG / thrombin, human 3870 UNT [EVARREST] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2572147 | fibrinogen, human 85 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2572149 | fibrinogen, human 85 MG/ML / thrombin, human 1200 UNT/ML [Evicel] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2572151 | fibrinogen, human 444 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2572152 | thrombin, human 1935 UNT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2572154 | fibrinogen, human 444 MG / thrombin, human 1935 UNT [EVARREST] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2572156 | fibrinogen, human 337 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2572157 | thrombin, human 123 UNT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2572159 | fibrinogen, human 337 MG / thrombin, human 123 UNT [TachoSil] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2572161 | fibrinogen, human 171 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2572162 | thrombin, human 62.2 UNT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2572164 | fibrinogen, human 171 MG / thrombin, human 62.2 UNT [TachoSil] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2572166 | fibrinogen, human 115 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2572167 | thrombin, human 600 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2572169 | fibrinogen, human 115 MG/ML / thrombin, human 600 UNT/ML [Tisseel] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2572171 | fibrinogen, human 106 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2572172 | thrombin, human 625 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2572174 | fibrinogen, human 106 MG/ML / thrombin, human 625 UNT/ML [Tisseel] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2572176 | thrombin, human 6.5 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2572178 | fibrinogen, human 106 MG/ML / thrombin, human 6.5 UNT/ML [Artiss] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2572180 | fibrinogen, human 1 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2572182 | fibrinogen, human 1 MG [RiaSTAP] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2572184 | fibrinogen, human 1 MG [Fibryga] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2572186 | fibrinogen, human 0.079 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2572187 | thrombin, human 0.699 UNT/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2572189 | fibrinogen, human 0.079 MG/MG / thrombin, human 0.699 UNT/MG [Raplixa] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2572191 | fibrinogen, human 80 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2572192 | thrombin, human 500 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2572195 | fibrinogen, human 80 MG/ML / thrombin, human 500 UNT/ML [Vistaseal] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2572208 | fibrinogen, human 90 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2572211 | fibrinogen, human 90 MG/ML / thrombin, human 500 UNT/ML [Tisseel] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2572283 | menatetrenone 0.2 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2572284 | cholecalciferol 1250 MCG / menatetrenone 200 MCG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2572284 | cholecalciferol 1250 MCG / menatetrenone 200 MCG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2572284 | cholecalciferol 1250 MCG / menatetrenone 200 MCG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2572292 | cycloSPORINE 0.05 % in 0.4 ML Ophthalmic Emulsion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2572292 | cycloSPORINE 0.05 % in 0.4 ML Ophthalmic Emulsion | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2572292 | cycloSPORINE 0.05 % in 0.4 ML Ophthalmic Emulsion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2572292 | cycloSPORINE 0.05 % in 0.4 ML Ophthalmic Emulsion | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2572292 | cycloSPORINE 0.05 % in 0.4 ML Ophthalmic Emulsion | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2572292 | cycloSPORINE 0.05 % in 0.4 ML Ophthalmic Emulsion | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2572292 | cycloSPORINE 0.05 % in 0.4 ML Ophthalmic Emulsion | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2572293 | Restasis 0.05 % in 0.4 ML Ophthalmic Emulsion | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2572293 | Restasis 0.05 % in 0.4 ML Ophthalmic Emulsion | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2572293 | Restasis 0.05 % in 0.4 ML Ophthalmic Emulsion | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2572293 | Restasis 0.05 % in 0.4 ML Ophthalmic Emulsion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2572293 | Restasis 0.05 % in 0.4 ML Ophthalmic Emulsion | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2572361 | varenicline 0.03 MG/ACTUAT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2572362 | varenicline Inhalant Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2572363 | varenicline Nasal Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2572364 | varenicline Nasal Spray | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2572365 | varenicline 0.03 MG/ACTUAT Nasal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2572365 | varenicline 0.03 MG/ACTUAT Nasal Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2572365 | varenicline 0.03 MG/ACTUAT Nasal Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2572366 | Tyrvaya | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2572367 | varenicline 0.03 MG/ACTUAT [Tyrvaya] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2572368 | Tyrvaya Inhalant Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2572369 | Tyrvaya Nasal Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2572370 | varenicline Nasal Spray [Tyrvaya] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2572371 | tyrvaya 0.03 MG/ACTUAT Nasal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2572371 | tyrvaya 0.03 MG/ACTUAT Nasal Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2572371 | tyrvaya 0.03 MG/ACTUAT Nasal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2572371 | tyrvaya 0.03 MG/ACTUAT Nasal Spray | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 25727 | Imidazolidinyl urea (in water) | Designated preferred name (PT) | NO | |
| RxCUI: 25727 | Imidazolidinyl urea (in water) | Designated preferred name (PT) | NO | |
| RxCUI: 25727 | Imidazolidinyl urea (in water) | Full form of descriptor (FN) | NO | |
| RxCUI: 25727 | Imidazolidinyl urea (in water) | Full form of descriptor (FN) | NO | |
| RxCUI: 25727 | Imidazolidinyl urea (in water) | Full form of descriptor (FN) | NO | |
| RxCUI: 25727 | Imidazolidinyl urea (in water) | Designated preferred name (PT) | NO | |
| RxCUI: 25727 | Imidazolidinyl urea (in water) | Full form of descriptor (FN) | NO | |
| RxCUI: 2573160 | durlobactam / sulbactam | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| RxCUI: 25734 | Gestodene | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 25734 | Gestodene | Designated preferred name (PT) | NO | |
| RxCUI: 25734 | Gestodene | Full form of descriptor (FN) | NO | |
| RxCUI: 25734 | Gestodene | Designated preferred name (PT) | NO | |
| RxCUI: 25734 | Gestodene | Full form of descriptor (FN) | NO | |
| RxCUI: 257466 | 21-hydroxylase antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 257466 | 21-hydroxylase antibody | Designated preferred name (PT) | NO | |
| RxCUI: 257466 | 21-hydroxylase antibody | Full form of descriptor (FN) | NO | |
| RxCUI: 257468 | 5-alpha-tetrahydrocortisol | Designated preferred name (PT) | NO | |
| RxCUI: 257468 | 5-alpha-tetrahydrocortisol | Full form of descriptor (FN) | NO | |
| RxCUI: 257473 | Alcelaphine herpesvirus 1 antibody | Designated preferred name (PT) | NO | |
| RxCUI: 257473 | Alcelaphine herpesvirus 1 antibody | Full form of descriptor (FN) | NO | |
| RxCUI: 257474 | Anaplasma marginale antibody | Designated preferred name (PT) | NO | |
| RxCUI: 257474 | Anaplasma marginale antibody | Full form of descriptor (FN) | NO | |
| RxCUI: 257486 | Avian adenovirus antibody | Designated preferred name (PT) | NO | |
| RxCUI: 257486 | Avian adenovirus antibody | Full form of descriptor (FN) | NO | |
| RxCUI: 257487 | Avian encephalomyelitis virus antibody | Designated preferred name (PT) | NO | |
| RxCUI: 257487 | Avian encephalomyelitis virus antibody | Full form of descriptor (FN) | NO | |
| RxCUI: 257492 | Avian infectious laryngotracheitis virus antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 257492 | Avian infectious laryngotracheitis virus antibody | Designated preferred name (PT) | NO | |
| RxCUI: 257492 | Avian infectious laryngotracheitis virus antibody | Full form of descriptor (FN) | NO | |
| RxCUI: 257495 | Avian paramyxovirus 2 antibody | Designated preferred name (PT) | NO | |
| RxCUI: 257495 | Avian paramyxovirus 2 antibody | Full form of descriptor (FN) | NO | |
| RxCUI: 257496 | Avian paramyxovirus 3 antibody | Designated preferred name (PT) | NO | |
| RxCUI: 257496 | Avian paramyxovirus 3 antibody | Full form of descriptor (FN) | NO | |
| RxCUI: 257500 | Babesia caballi antibody | Designated preferred name (PT) | NO | |
| RxCUI: 257500 | Babesia caballi antibody | Full form of descriptor (FN) | NO | |
| RxCUI: 257517 | Blastomyces species antibody | Designated preferred name (PT) | NO | |
| RxCUI: 257517 | Blastomyces species antibody | Full form of descriptor (FN) | NO | |
| RxCUI: 257531 | Bluetongue virus antibody | Designated preferred name (PT) | NO | |
| RxCUI: 257531 | Bluetongue virus antibody | Full form of descriptor (FN) | NO | |
| RxCUI: 257535 | Bordetella avium antibody | Designated preferred name (PT) | NO | |
| RxCUI: 257535 | Bordetella avium antibody | Full form of descriptor (FN) | NO | |
| RxCUI: 257536 | Antigen of Bordetella parapertussis | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 257536 | Antigen of Bordetella parapertussis | Full form of descriptor (FN) | NO | |
| RxCUI: 257536 | Antigen of Bordetella parapertussis | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 257536 | Antigen of Bordetella parapertussis | Designated preferred name (PT) | NO | |
| RxCUI: 257549 | Bovine herpesvirus 1 antibody | Designated preferred name (PT) | NO | |
| RxCUI: 257549 | Bovine herpesvirus 1 antibody | Full form of descriptor (FN) | NO | |
| RxCUI: 257550 | Antigen of Bovine herpesvirus 1 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 257550 | Antigen of Bovine herpesvirus 1 | Full form of descriptor (FN) | NO | |
| RxCUI: 257550 | Antigen of Bovine herpesvirus 1 | Designated preferred name (PT) | NO | |
| RxCUI: 257550 | Antigen of Bovine herpesvirus 1 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 257552 | Antigen of Bovine herpesvirus 4 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 257552 | Antigen of Bovine herpesvirus 4 | Full form of descriptor (FN) | NO | |
| RxCUI: 257552 | Antigen of Bovine herpesvirus 4 | Designated preferred name (PT) | NO | |
| RxCUI: 257552 | Antigen of Bovine herpesvirus 4 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 257562 | Brucella ovis antibody | Designated preferred name (PT) | NO | |
| RxCUI: 257562 | Brucella ovis antibody | Full form of descriptor (FN) | NO | |
| RxCUI: 257564 | Cache valley virus antibody | Designated preferred name (PT) | NO | |
| RxCUI: 257564 | Cache valley virus antibody | Full form of descriptor (FN) | NO | |
| RxCUI: 257565 | Anti-calcitonin antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 257565 | Anti-calcitonin antibody | Designated preferred name (PT) | NO | |
| RxCUI: 257565 | Anti-calcitonin antibody | Full form of descriptor (FN) | NO | |
| RxCUI: 257569 | Caprine arthritis encephalitis virus antibody | Designated preferred name (PT) | NO | |
| RxCUI: 257569 | Caprine arthritis encephalitis virus antibody | Full form of descriptor (FN) | NO | |
| RxCUI: 257580 | Cerebroside sulfatase B | Designated preferred name (PT) | NO | |
| RxCUI: 257580 | Cerebroside sulfatase B | Full form of descriptor (FN) | NO | |
| RxCUI: 257584 | Chicken anaemia virus antibody | British preferred term (PTGB) | NO | |
| RxCUI: 257584 | Chicken anaemia virus antibody | Designated preferred name (PT) | NO | |
| RxCUI: 257584 | Chicken anaemia virus antibody | Full form of descriptor (FN) | NO | |
| RxCUI: 257600 | Antigen of Clostridium chauvoei | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 257600 | Antigen of Clostridium chauvoei | Full form of descriptor (FN) | NO | |
| RxCUI: 257600 | Antigen of Clostridium chauvoei | Designated preferred name (PT) | NO | |
| RxCUI: 257600 | Antigen of Clostridium chauvoei | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 257602 | Clostridium septicum Ag | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 257602 | Clostridium septicum Ag | Full form of descriptor (FN) | NO | |
| RxCUI: 257602 | Clostridium septicum Ag | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 257602 | Clostridium septicum Ag | Designated preferred name (PT) | NO | |
| RxCUI: 257603 | Antigen of Paeniclostridium sordellii | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 257603 | Antigen of Paeniclostridium sordellii | Full form of descriptor (FN) | NO | |
| RxCUI: 257603 | Antigen of Paeniclostridium sordellii | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 257603 | Antigen of Paeniclostridium sordellii | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 257603 | Antigen of Paeniclostridium sordellii | Designated preferred name (PT) | NO | |
| RxCUI: 257606 | Antigen of Coccidioides immitis | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 257606 | Antigen of Coccidioides immitis | Full form of descriptor (FN) | NO | |
| RxCUI: 257606 | Antigen of Coccidioides immitis | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 257606 | Antigen of Coccidioides immitis | Designated preferred name (PT) | NO | |
| RxCUI: 257615 | Collagen type IV antigen | Designated preferred name (PT) | NO | |
| RxCUI: 257615 | Collagen type IV antigen | Full form of descriptor (FN) | NO | |
| RxCUI: 257624 | Corynebacterium diphtheriae antibody | Designated preferred name (PT) | NO | |
| RxCUI: 257624 | Corynebacterium diphtheriae antibody | Full form of descriptor (FN) | NO | |
| RxCUI: 257642 | Dicarboxylporphyrin | Designated preferred name (PT) | NO | |
| RxCUI: 257642 | Dicarboxylporphyrin | Full form of descriptor (FN) | NO | |
| RxCUI: 257646 | Duck enteritis virus antibody | Designated preferred name (PT) | NO | |
| RxCUI: 257646 | Duck enteritis virus antibody | Full form of descriptor (FN) | NO | |
| RxCUI: 257646 | Duck enteritis virus antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 257672 | Epizootic hemorrhagic disease virus antibody | British preferred term (PTGB) | NO | |
| RxCUI: 257672 | Epizootic hemorrhagic disease virus antibody | Designated preferred name (PT) | NO | |
| RxCUI: 257672 | Epizootic hemorrhagic disease virus antibody | Full form of descriptor (FN) | NO | |
| RxCUI: 257687 | Soluble cell antigen antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 257687 | Soluble cell antigen antibody | Designated preferred name (PT) | NO | |
| RxCUI: 257687 | Soluble cell antigen antibody | Full form of descriptor (FN) | NO | |
| RxCUI: 257687 | Soluble cell antigen antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 257687 | Soluble cell antigen antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 257687 | Soluble cell antigen antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 257687 | Soluble cell antigen antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 257690 | Foetal fibronectin | Designated preferred name (PT) | NO | |
| RxCUI: 257690 | Foetal fibronectin | Full form of descriptor (FN) | NO | |
| RxCUI: 257690 | Foetal fibronectin | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 257709 | Anti-glutamate decarboxylase 65 antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 257709 | Anti-glutamate decarboxylase 65 antibody | Designated preferred name (PT) | NO | |
| RxCUI: 257709 | Anti-glutamate decarboxylase 65 antibody | Full form of descriptor (FN) | NO | |
| RxCUI: 257725 | Warm hemolysin | British preferred term (PTGB) | NO | |
| RxCUI: 257725 | Warm hemolysin | Designated preferred name (PT) | NO | |
| RxCUI: 257725 | Warm hemolysin | Full form of descriptor (FN) | NO | |
| RxCUI: 257754 | HIV 2 p41 antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 257754 | HIV 2 p41 antibody | Designated preferred name (PT) | NO | |
| RxCUI: 257754 | HIV 2 p41 antibody | Full form of descriptor (FN) | NO | |
| RxCUI: 257762 | HTLV 1 gp46 antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 257762 | HTLV 1 gp46 antibody | Designated preferred name (PT) | NO | |
| RxCUI: 257762 | HTLV 1 gp46 antibody | Full form of descriptor (FN) | NO | |
| RxCUI: 257763 | HTLV 1 p19 antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 257763 | HTLV 1 p19 antibody | Designated preferred name (PT) | NO | |
| RxCUI: 257763 | HTLV 1 p19 antibody | Full form of descriptor (FN) | NO | |
| RxCUI: 257764 | HTLV 1 p24 antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 257764 | HTLV 1 p24 antibody | Designated preferred name (PT) | NO | |
| RxCUI: 257764 | HTLV 1 p24 antibody | Full form of descriptor (FN) | NO | |
| RxCUI: 257765 | HTLV 1 p26 antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 257765 | HTLV 1 p26 antibody | Designated preferred name (PT) | NO | |
| RxCUI: 257765 | HTLV 1 p26 antibody | Full form of descriptor (FN) | NO | |
| RxCUI: 257766 | HTLV 1 p28 antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 257766 | HTLV 1 p28 antibody | Designated preferred name (PT) | NO | |
| RxCUI: 257766 | HTLV 1 p28 antibody | Full form of descriptor (FN) | NO | |
| RxCUI: 257767 | HTLV 1 p32 antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 257767 | HTLV 1 p32 antibody | Designated preferred name (PT) | NO | |
| RxCUI: 257767 | HTLV 1 p32 antibody | Full form of descriptor (FN) | NO | |
| RxCUI: 257768 | HTLV 1 p36 antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 257768 | HTLV 1 p36 antibody | Designated preferred name (PT) | NO | |
| RxCUI: 257768 | HTLV 1 p36 antibody | Full form of descriptor (FN) | NO | |
| RxCUI: 257769 | HTLV 1 p53 antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 257769 | HTLV 1 p53 antibody | Designated preferred name (PT) | NO | |
| RxCUI: 257769 | HTLV 1 p53 antibody | Full form of descriptor (FN) | NO | |
| RxCUI: 257770 | HTLV 1 rgp21 antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 257770 | HTLV 1 rgp21 antibody | Designated preferred name (PT) | NO | |
| RxCUI: 257770 | HTLV 1 rgp21 antibody | Full form of descriptor (FN) | NO | |
| RxCUI: 257791 | Infectious bursal disease virus antibody | Designated preferred name (PT) | NO | |
| RxCUI: 257791 | Infectious bursal disease virus antibody | Full form of descriptor (FN) | NO | |
| RxCUI: 257793 | Antibody to intercalated disc of myocardium | Designated preferred name (PT) | NO | |
| RxCUI: 257793 | Antibody to intercalated disc of myocardium | Full form of descriptor (FN) | NO | |
| RxCUI: 257793 | Antibody to intercalated disc of myocardium | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2578 | Clemastine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2578 | Clemastine | Designated preferred name (PT) | YES | |
| RxCUI: 2578 | Clemastine | Full form of descriptor (FN) | YES | |
| RxCUI: 2578 | Clemastine | Designated preferred name (PT) | YES | |
| RxCUI: 2578 | Clemastine | Full form of descriptor (FN) | YES | |
| RxCUI: 257844 | Mefenamate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 257844 | Mefenamate | Designated preferred name (PT) | YES | |
| RxCUI: 257844 | Mefenamate | Full form of descriptor (FN) | YES | |
| RxCUI: 257847 | Long acting metabolite of methadone | Designated preferred name (PT) | NO | |
| RxCUI: 257847 | Long acting metabolite of methadone | Full form of descriptor (FN) | NO | |
| RxCUI: 257854 | Mycoplasma fermentans antibody | Designated preferred name (PT) | NO | |
| RxCUI: 257854 | Mycoplasma fermentans antibody | Full form of descriptor (FN) | NO | |
| RxCUI: 257855 | Mycoplasma gallisepticum antibody | Designated preferred name (PT) | NO | |
| RxCUI: 257855 | Mycoplasma gallisepticum antibody | Full form of descriptor (FN) | NO | |
| RxCUI: 257856 | Mycoplasma hominis antibody | Designated preferred name (PT) | NO | |
| RxCUI: 257856 | Mycoplasma hominis antibody | Full form of descriptor (FN) | NO | |
| RxCUI: 257857 | Mycoplasma meleagridis antibody | Designated preferred name (PT) | NO | |
| RxCUI: 257857 | Mycoplasma meleagridis antibody | Full form of descriptor (FN) | NO | |
| RxCUI: 257860 | Mycoplasma synoviae antibody | Designated preferred name (PT) | NO | |
| RxCUI: 257860 | Mycoplasma synoviae antibody | Full form of descriptor (FN) | NO | |
| RxCUI: 257877 | Neisseria meningitidis polyvalent antibody | Designated preferred name (PT) | NO | |
| RxCUI: 257877 | Neisseria meningitidis polyvalent antibody | Full form of descriptor (FN) | NO | |
| RxCUI: 257882 | Neospora caninum antibody | Designated preferred name (PT) | NO | |
| RxCUI: 257882 | Neospora caninum antibody | Full form of descriptor (FN) | NO | |
| RxCUI: 257886 | Neuronal antinuclear antibody type II | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 257886 | Neuronal antinuclear antibody type II | Designated preferred name (PT) | NO | |
| RxCUI: 257886 | Neuronal antinuclear antibody type II | Full form of descriptor (FN) | NO | |
| RxCUI: 257886 | Neuronal antinuclear antibody type II | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 25789 | glimepiride | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 25789 | glimepiride | Designated preferred name (PT) | YES | |
| RxCUI: 25789 | glimepiride | Full form of descriptor (FN) | YES | |
| RxCUI: 25789 | glimepiride | Designated preferred name (PT) | YES | |
| RxCUI: 25789 | glimepiride | Full form of descriptor (FN) | YES | |
| RxCUI: 257897 | Normaprotiline | Designated preferred name (PT) | NO | |
| RxCUI: 257897 | Normaprotiline | Full form of descriptor (FN) | NO | |
| RxCUI: 2579 | Clemizole | Designated preferred name (PT) | NO | |
| RxCUI: 2579 | Clemizole | Full form of descriptor (FN) | NO | |
| RxCUI: 257903 | Bovine osteocalcin | Designated preferred name (PT) | NO | |
| RxCUI: 257903 | Bovine osteocalcin | Full form of descriptor (FN) | NO | |
| RxCUI: 257908 | Antigen of Human papilloma virus 31 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 257908 | Antigen of Human papilloma virus 31 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 257908 | Antigen of Human papilloma virus 31 | Full form of descriptor (FN) | NO | |
| RxCUI: 257908 | Antigen of Human papilloma virus 31 | Designated preferred name (PT) | NO | |
| RxCUI: 257908 | Antigen of Human papilloma virus 31 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 257913 | Antigen of Human papilloma virus 44 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 257913 | Antigen of Human papilloma virus 44 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 257913 | Antigen of Human papilloma virus 44 | Full form of descriptor (FN) | NO | |
| RxCUI: 257913 | Antigen of Human papilloma virus 44 | Designated preferred name (PT) | NO | |
| RxCUI: 257913 | Antigen of Human papilloma virus 44 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 257914 | Antigen of Human papilloma virus 45 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 257914 | Antigen of Human papilloma virus 45 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 257914 | Antigen of Human papilloma virus 45 | Full form of descriptor (FN) | NO | |
| RxCUI: 257914 | Antigen of Human papilloma virus 45 | Designated preferred name (PT) | NO | |
| RxCUI: 257914 | Antigen of Human papilloma virus 45 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 257920 | Para-aminosalicylate | Designated preferred name (PT) | NO | |
| RxCUI: 257920 | Para-aminosalicylate | Full form of descriptor (FN) | NO | |
| RxCUI: 25793 | gliquidone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 25793 | gliquidone | Designated preferred name (PT) | NO | |
| RxCUI: 25793 | gliquidone | Full form of descriptor (FN) | NO | |
| RxCUI: 25793 | gliquidone | Designated preferred name (PT) | NO | |
| RxCUI: 25793 | gliquidone | Full form of descriptor (FN) | NO | |
| RxCUI: 257935 | Pasteurella multocida antibody | Designated preferred name (PT) | NO | |
| RxCUI: 257935 | Pasteurella multocida antibody | Full form of descriptor (FN) | NO | |
| RxCUI: 257937 | Penicillium species antibody | Designated preferred name (PT) | NO | |
| RxCUI: 257937 | Penicillium species antibody | Full form of descriptor (FN) | NO | |
| RxCUI: 257953 | Pseudorabies virus antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 257953 | Pseudorabies virus antibody | Designated preferred name (PT) | NO | |
| RxCUI: 257953 | Pseudorabies virus antibody | Full form of descriptor (FN) | NO | |
| RxCUI: 257970 | Rickettsia typhi antibody | Designated preferred name (PT) | NO | |
| RxCUI: 257970 | Rickettsia typhi antibody | Full form of descriptor (FN) | NO | |
| RxCUI: 257972 | Ribonucleic acid antibody | Designated preferred name (PT) | NO | |
| RxCUI: 257972 | Ribonucleic acid antibody | Full form of descriptor (FN) | NO | |
| RxCUI: 257981 | Sarcocystis neurona antibody | Designated preferred name (PT) | NO | |
| RxCUI: 257981 | Sarcocystis neurona antibody | Full form of descriptor (FN) | NO | |
| RxCUI: 257982 | Antigen of Sarcocystis neurona | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 257982 | Antigen of Sarcocystis neurona | Full form of descriptor (FN) | NO | |
| RxCUI: 257982 | Antigen of Sarcocystis neurona | Designated preferred name (PT) | NO | |
| RxCUI: 257982 | Antigen of Sarcocystis neurona | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |